A Double-blind, Placebo-controlled Trial to Determine the Effects of Zafirlukast (80 mg bd) and Beclomethasone Dipropionate (200mg bd), Given for 7 Days, on the Cellular Responses in the Airways to Inhaled Allergen Challenge (9188IL/0109).
Study identifier:9188IL/0109
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Double-blind, Placebo-controlled Trial to Determine the Effects of Zafirlukast (80 mg bd) and Beclomethasone Dipropionate (200mg bd), Given for 7 Days, on the Cellular Responses in the Airways to Inhaled Allergen Challenge (9188IL/0109).
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Feb 1997
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
